Compounds > 3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol
Page last updated: 2024-08-16

3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol and 5-hydroxy-1-methyl-2--(di-n-propylamino)tetralin methyl ether

3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol has been researched along with 5-hydroxy-1-methyl-2--(di-n-propylamino)tetralin methyl ether in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kleven, MS; Koek, W1

Other Studies

1 other study(ies) available for 3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol and 5-hydroxy-1-methyl-2--(di-n-propylamino)tetralin methyl ether

ArticleYear
Dopamine D2 receptors play a role in the (-)-apomorphine-like discriminative stimulus effects of (+)-PD 128907.
    European journal of pharmacology, 1997, Feb-19, Volume: 321, Issue:1

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Apomorphine; Benzopyrans; Conditioning, Operant; Discrimination, Psychological; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Male; Oxazines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2

1997